Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2238)
All Articles published online
|
Jan 21, 2005 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jia L, Zhang MH, Yuan SZ, Huang WG. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. World J Gastroenterol 2005; 11(3): 447-450 [PMID: 15637766 DOI: 10.3748/wjg.v11.i3.447] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/447.htm |
| Number | Citing Articles |
| 1 |
Murielle Mimeault, Randall E Brand, Aaron A Sasson, Surinder K Batra. Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies. Pancreas 2005; 31(4): 301 doi: 10.1097/01.mpa.0000175893.04660.1b
|
| 2 |
Berta Laquente, Cristina Lacasa, Mireia M. Ginestà, Oriol Casanovas, Agnès Figueras, Maica Galán, Ignacio García Ribas, Josep Ramon Germà, Gabriel Capellà, Francesc Viñals. Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model. Molecular Cancer Therapeutics 2008; 7(3): 638 doi: 10.1158/1535-7163.MCT-07-2122
|
| 3 |
Hagit Mann-Steinberg, Ronit Satchi-Fainaro. Angiogenesis. 2008; : 395 doi: 10.1007/978-0-387-71518-6_35
|
| 4 |
Han Hsi Wong, Nicholas R. Lemoine. Biological Approaches to Therapy of Pancreatic Cancer. Pancreatology 2008; 8(4-5): 431 doi: 10.1159/000151536
|
| 5 |
Giuseppe Garcea, Helena Doucas, Will P. Steward, Ashley R. Dennison, David P. Berry. HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER. ANZ Journal of Surgery 2006; 76(9): 830 doi: 10.1111/j.1445-2197.2006.03872.x
|
| 6 |
Keiichi Suzuki, Koichi Aiura, Sachiko Matsuda, Osamu Itano, Osamu Takeuchi, Kazuo Umezawa, Yuko Kitagawa. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer. Clinical & Experimental Metastasis 2013; 30(4): 381 doi: 10.1007/s10585-012-9544-7
|
| 7 |
Yasuyuki Amoh, Lingna Li, Kazuhiko Tsuji, A.R. Moossa, Kensei Katsuoka, Robert M. Hoffman, Michael Bouvet. Dual-Color Imaging of Nascent Blood Vessels Vascularizing Pancreatic Cancer in an Orthotopic Model Demonstrates Antiangiogenesis Efficacy of Gemcitabine. Journal of Surgical Research 2006; 132(2): 164 doi: 10.1016/j.jss.2005.12.028
|
| 8 |
Aarthi Gopinathan, David A. Tuveson. The use of GEM models for experimental cancer therapeutics. Disease Models & Mechanisms 2008; 1(2-3): 83 doi: 10.1242/dmm.000570
|
| 9 |
Xiaowen Yu, Qingqing Yang, Sensen Lin, Shengtao Yuan, Li Sun. Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivo. Oncology Reports 2017; 37(3): 1756 doi: 10.3892/or.2017.5373
|
| 10 |
Xue-fen Wang, Ling-fang Tu, Li-hong Wang, Jian-ying Zhou. Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. Journal of Zhejiang University SCIENCE B 2006; 7(10): 837 doi: 10.1631/jzus.2006.B0837
|
| 11 |
Hye‐Lim Ju, Kwang‐Hyub Han, Jong Doo Lee, Simon Weonsang Ro. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy. International Journal of Cancer 2016; 138(7): 1601 doi: 10.1002/ijc.29703
|
| 12 |
Lin Jia, Yuan-Yuan Shang, Yu-Yuan Li. Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice. World Journal of Gastroenterology 2008; 14(27): 4377-4382 doi: 10.3748/wjg.14.4377
|
| 13 |
Michael R. Horsman, Dietmar W. Siemann. Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 2006; 66(24): 11520 doi: 10.1158/0008-5472.CAN-06-2848
|
| 14 |
J. Al Shemaili, E. Mensah-Brown, K. Parekh, S.A. Thomas, S. Attoub, B. Hellman, F. Nyberg, A. Adem, P. Collin, T.E. Adrian. Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer. European Journal of Cancer 2014; 50(7): 1391 doi: 10.1016/j.ejca.2014.01.002
|
| 15 |
Qi Xie, Lin Jia, Yan-Hong Liu, Cheng-Gang Wei. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer <italic>in vivo</italic>. World Journal of Gastroenterology 2009; 15(6): 737-741 doi: 10.3748/wjg.15.737
|
| 16 |
Goutam Mondal, Virender Kumar, Surendra K. Shukla, Pankaj K. Singh, Ram I. Mahato. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules 2016; 17(1): 301 doi: 10.1021/acs.biomac.5b01419
|
| 17 |
Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour‐Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Journal of Cellular Physiology 2017; 232(11): 2931 doi: 10.1002/jcp.25798
|
| 18 |
Marta Vives, Berta Laquente, Francesc Viñals. Metronomic Chemotherapy. 2014; : 53 doi: 10.1007/978-3-662-43604-2_4
|
| 19 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
|